A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Investor Catalyst Hub Virtual Monthly Meeting

Virtual Event Virtual Event

Ileana Hancu, Ph.D., ARPA-H Program Manager for the Precision Surgical Interventions (PSI) program, will join us to give an overview of her program and how entities can contribute at different […]

Free

Investor Catalyst Hub Virtual Monthly Meeting

Virtual Event Virtual Event

We will be joined by Daria Fedyukina, Ph.D., ARPA-H Program Manager, who specializes in translational science and commercialization strategies involving cell and gene therapies, and Stan Wang, M.D., Ph.D., Founder […]

Free

SPOKES Session: A Virtual Networking Mixer

Virtual Event Virtual Event

Spokes: Register today! We are excited to invite you to the first Strategic Problem-solving for Optimal Knowledge-sharing and Enhancing Solutions (SPOKES) Session! These members-only meetings provide an opportunity for spoke-to-spoke […]

Free

ARPA-H Investor Catalyst Hub Monthly Virtual Meeting

Virtual Event Virtual Event

Kimberley Steele, M.D., Ph.D., ARPA-H Program Manager, will join the Investor Catalyst Hub’s April member meeting to discuss the importance of lymphatics in health. Dr. Steele, an internationally recognized expert […]

Free

ARPANET-H Overview and Q&A Session

Virtual Event Virtual Event

Join us for our first joint members-only meeting hosted by the Customer Experience Hub and Investor Catalyst Hub. You will gain a comprehensive overview of the ARPANET-H network, its remarkable capabilities, and the many benefits it offers to our valued members.

Free

Portal-Bayer Co.Lab Cocktail Reception with ARPA-H and MGB GCTI

238 Main Street 238 Main Street, Cambridge, MA, United States

Portal Biotechnologies is excited to be partnering with Bayer Co.Lab for a special cocktail reception with the ARPA-H Investor Catalyst Hub and Massachusetts General Brigham Gene and Cell Therapy Institute (GCTI).

Free